Join our upcoming CMC Biopharma MasterClass which will be streamed ONLINE on 27-28 July, 2020 and will be led by Dr Andreu Soldevila, Founder and CEO of Leanbio and Co-founder and CEO of Syna Therapeutics. This MasterClass will provide a deep and detailed instruction on Chemistry, Manufacturing and Controls (CMC) requirements and review processes for clinical trial, registration and postapproval drug applications. Attendees will also have a solid but comprehensive overview of all relevant regulatory, technical and quality elements, implementation and documentation of the required CMC analytical and stability knowledge for biotechnology products, including biosimilar products. Learning outcomes include: Process development strategies Analytical and Formulation development GMP manufacture Process analytical Technology Guidelines and Regulatory pathways for New Biological entities and Biosimilars For more information, download the Agenda!
Costs: n/a
Event type: Seminars, workshops and presentations
Registration information: n/a
Event website: https://glceurope.com/cmc-biopharma-masterclass-4-details/?utm_source=smartmoney_match&utm_medium=media_partner&utm_campaign=CMCBPMC4
Posted by: Adam Soos